In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments. In a paper published in the journal Nature Communications, University of California, San Diego School of Medicine researchers ...
Sep 3, 2015
0
7
Adding the price tag to prescription medicines worth more than £20 in England is just a "headline grabbing gimmick," which, among other things, could potentially mislead patients into believing that cheaper drugs are somehow ...
Aug 6, 2015
0
10
There is very little evidence to recommend avoiding certain types of dietary carbohydrate, known as the FODMAP diet, to ease the symptoms of irritable bowel syndrome, or IBS for short, concludes a review of the available ...
Aug 6, 2015
0
18
The number of new Ebola cases is tapering off, but the search for new treatments continues. Now, one research team has found potential drug candidates that successfully treated up to 90 percent of mice exposed to the Ebola ...
May 20, 2015
1
17
Scientists on Monday said they had unlocked a pathway for producing opiates from genetically-engineered yeast but feared the discovery could one day be a bonanza for drug lords.
May 18, 2015
0
13
Research led by Charles Nichols, PhD, Associate Professor of Pharmacology and Experimental Therapeutics at the LSU Health New Orleans School of Medicine, has found that a psychedelic drug, (R)-DOI, prevents the development ...
Feb 9, 2015
0
22
Scientists at the University of York have discovered that a drug used widely to combat epilepsy has the potential to reduce the growth and spread of breast cancer.
Jan 27, 2015
0
4
Cancer Research UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults, according to research published in Molecular Cancer Therapeutics.
Jan 14, 2015
0
11
The fixed combination of canagliflozin with metformin (trade name: Vokanamet) has been approved since April 2014 for adults with type 2 diabetes mellitus in whom diet and exercise do not provide adequate glycaemic control. ...
Nov 21, 2014
0
0
In a second presentation looking at new ways of treating non-small cell lung cancer (NSCLC) that has both the EGFR and T790M mutations, researchers will tell the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer ...
Nov 20, 2014
0
1
